Vestor Capital LLC Sells 2,300 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Vestor Capital LLC lessened its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 48.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,401 shares of the pharmacy operator’s stock after selling 2,300 shares during the period. Vestor Capital LLC’s holdings in Walgreens Boots Alliance were worth $63,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in WBA. Highlander Capital Management LLC acquired a new stake in Walgreens Boots Alliance in the 4th quarter valued at $26,000. Venturi Wealth Management LLC grew its holdings in shares of Walgreens Boots Alliance by 1,241.8% in the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Walgreens Boots Alliance by 308.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 845 shares in the last quarter. Rocky Mountain Advisers LLC bought a new position in Walgreens Boots Alliance during the 4th quarter valued at about $30,000. Finally, Planned Solutions Inc. acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at about $34,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Stock Up 0.1 %

WBA stock traded up $0.02 during mid-day trading on Thursday, reaching $17.25. The company had a trading volume of 6,060,177 shares, compared to its average volume of 13,269,616. Walgreens Boots Alliance, Inc. has a 52 week low of $17.13 and a 52 week high of $32.89. The company has a market capitalization of $14.88 billion, a price-to-earnings ratio of -2.46, a PEG ratio of 1.10 and a beta of 0.80. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. The stock has a 50 day simple moving average of $19.35 and a two-hundred day simple moving average of $21.50.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The company had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.16 EPS. As a group, equities analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st will be given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 5.80%. The ex-dividend date of this dividend is Monday, May 20th. Walgreens Boots Alliance’s payout ratio is presently -14.29%.

Wall Street Analysts Forecast Growth

WBA has been the subject of a number of research reports. Morgan Stanley lowered their target price on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a research note on Monday, April 1st. Leerink Partnrs reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Truist Financial reiterated a “hold” rating and issued a $25.00 price target on shares of Walgreens Boots Alliance in a report on Monday, April 1st. UBS Group dropped their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a report on Wednesday, April 3rd. Finally, HSBC reaffirmed a “reduce” rating and issued a $20.00 target price (down previously from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $24.36.

Insider Transactions at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari bought 3,000 shares of the firm’s stock in a transaction dated Thursday, April 11th. The shares were bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of the business’s stock in a transaction on Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Inderpal S. Bhandari bought 3,000 shares of the stock in a transaction dated Thursday, April 11th. The shares were acquired at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by corporate insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.